Literature DB >> 6840849

Streptococcal growth and toxin production in vivo.

J L Duncan.   

Abstract

Streptococcal growth in vivo was studied with inoculated micropore filter chambers which were implanted into the peritoneal cavities of mice. Eight of nine group A strains and one group B strain grew in vivo, achieving concentrations of 10(7) to 10(9) CFU/ml in the chambers. Experiments with the Richards strain showed that the number of viable organisms remained high at 5 and 8 weeks after infection. The use of specific inhibitors and appropriate toxin-negative strains demonstrated that both cytolytic toxins produced by group A streptococci, streptolysin S and streptolysin O, were present in the culture fluids harvested from the chambers. This finding represents the first evidence that streptolysin S is produced in vivo. The host response to streptococci growing in vivo was examined by following the increase in serum antistreptolysin O levels. The response was first detected 2 weeks after chamber implantation and appeared to be maximal after 5 weeks. In addition, the production of antibody to streptococcal cell surface antigens was demonstrated indirectly with fluorescein-labeled anti-mouse immunoglobulin G.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840849      PMCID: PMC264883          DOI: 10.1128/iai.40.2.501-505.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Renal tubular lesions in mice produced by group A streptococci grown in intraperitoneal diffusion chambers.

Authors:  E M TAN; D B HACKEL; M H KAPLAN
Journal:  J Infect Dis       Date:  1961 Jan-Feb       Impact factor: 5.226

2.  Renal lesions produced by group A, type 12, streptococci.

Authors:  D K KELLY; J F WINN
Journal:  Science       Date:  1958-06-06       Impact factor: 47.728

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  A simple method for the study in vivo of bacterial growth and accompanying host response.

Authors:  S E Day; K K Vasli; R J Russell; J P Arbuthnott
Journal:  J Infect       Date:  1980-03       Impact factor: 6.072

5.  Tissue cages for study of experimental streptococcal infection in rabbits. I. Production of erythrogenic toxins in vivo.

Authors:  H Knöll; S E Holm; D Gerlach; W Köhler
Journal:  Immunobiology       Date:  1982       Impact factor: 3.144

Review 6.  Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin).

Authors:  J E Alouf
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

7.  Neisseria gonorrhoeae: experimental infection of laboratory animals.

Authors:  R J Arko
Journal:  Science       Date:  1972-09-29       Impact factor: 47.728

8.  Differential ability of colonial types of Neisseria gonorrhoeae to produce infection cutaneous perforated plastic chambers in guinea-pigs and rabbits.

Authors:  D R Veale; H Smith; K A Witt; R B Marshall
Journal:  J Med Microbiol       Date:  1975-05       Impact factor: 2.472

9.  Properties of Escherichia coli grown in vivo using a chamber implant system.

Authors:  T M Finn; J P Arbuthnott; G Dougan
Journal:  J Gen Microbiol       Date:  1982-12

10.  Growth of group B streptococci and development of surface antigens in tissue cages implanted in rabbits.

Authors:  M Wagner; S E Holm; B Wagner
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1982-07
View more
  4 in total

1.  Detection of anti-Vibrio vulnificus cytolysin antibodies in sera from mice and a human surviving V. vulnificus disease.

Authors:  L D Gray; A S Kreger
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

2.  Colonial dissociation and susceptibility to phagocytosis of Pseudomonas aeruginosa grown in a chamber implant model in mice.

Authors:  N M Kelly; J L Battershill; S Kuo; J P Arbuthnott; R E Hancock
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

3.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.

Authors:  S J Hultgren; T N Porter; A J Schaeffer; J L Duncan
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

4.  Cytolytic activity and virulence of Vibrio damsela.

Authors:  A S Kreger
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.